Document:

Exhibit 10.2

 

SEVERANCE
AND CONSULTING AGREEMENT AND GENERAL RELEASE

 

This
Severance and Consulting Agreement and General Release (this “Agreement” or this “Agreement and General Release”),
dated January 29, 2020, is entered into by James Early (“Executive”) and Interpace Biosciences, Inc. (the
“Company”). Executive and the Company are jointly referred to in this Agreement as the “Parties” and both
individually referred to in this Agreement as a “Party.”

 

1.
Termination of Employment. The Parties acknowledge and agree that Executive’s employment with the Company
and its affiliates will terminate on January 29, 2020 (the “Employment Termination Date”) and that such termination
of employment will not constitute a “separation from service” under Section 409A of the Internal Revenue Code of 1986,
as amended (the “Code”) due to the Executive’s engagement as a consultant by the Company pursuant to Section
2. Irrespective of whether Executive signs this Agreement, (a) to the extent unpaid, Company shall pay Executive on the first
payroll date following the Employment Termination Date for Executive’s accrued salary and accrued and unused PTO days through
the Employment Termination Date, and (b) Executive shall be entitled to retain possession of his laptop computer, monitor, cell
phone and iPad. Executive’s participation in the Company’s group health insurance plan will end on the Employment
Termination Date, and to the extent provided by COBRA and by the Company’s current group health insurance policies, Executive
will be eligible to continue Executive’s group health insurance benefits at Executive’s own expense. Upon the Employment
Termination Date, (i) the Company shall cause Executive’s outstanding restricted stock unit awards to vest in full as of
such date and (ii) the Company shall grant to Executive a new award of 5,000 restricted stock units under the Company’s
2019 Equity Incentive Plan (the “Plan”), subject to the terms and conditions of the Plan and an applicable award agreement,
which shall be eligible to vest in full on the six-month anniversary of the Employment Termination Date, subject to Executive’s
continuous service with the Company through such vesting date. With respect to Executive’s equity awards outstanding on
the Employment Termination Date, notwithstanding anything in the Company’s equity incentive plans or the applicable equity
award agreements to the contrary: (i) such equity awards shall remain eligible to vest in accordance with their terms based on
Executive’s continued service during the Consulting Term (as defined below), and (ii) any such equity awards that are stock
options that are vested on the Consulting Termination Date (as defined below) shall remain exercisable through the 90th
day following the Consulting Termination Date (or, if earlier, the stated term of the applicable stock option).

 

    	 	 	 

    	 

    

 

2.
Consulting Services.

 

	 	i.	During
    the Consulting Term, Executive shall provide certain consulting services (the “Services”) by means of his consulting
    firm, Early Financial Consulting, LLC, to the Company as the Company’s Chief Executive Officer, Chief Financial Officer
    and/or other senior management employees of the Company may from time to time request and deem appropriate, including, but
    not limited to finance and accounting services. While working at a site other than the Company’s offices, Executive
    will be responsible for providing its own supplies and office equipment. Executive represents and warrants that it has the
    skill, expertise, and experience to perform the Services in accordance with all applicable laws.
	 	 	 
	 	ii.	In
    consideration of Executive’s expertise related to the Services, Executive’s acceptance of this Agreement, and
    of Executive’s performance of the Services as set forth herein, the Company shall pay the Executive by means of his
    consulting firm, Early Financial Consulting, LLC, an hourly fee of $350; provided, however, that the maximum aggregate fees
    payable by the Company to Executive for the Services pursuant to this Section 2 shall in no event exceed an aggregate total
    of $210,000. The Parties agree that the estimated number of hours of Services is up to 100 per month, for a period of up to
    six (6) months, subject to the Company’s need in its discretion. Invoices for Services (cash compensated) and expenses
    will be submitted by the Executive to the Company on a regular but no less than weekly basis and shall clearly identify the
    Executive’s business name, address, and Federal Tax ID Number. The Company will pay such invoices within 15 days upon
    receipt of invoice. The Company will not withhold any federal, state or local income, Social Security, unemployment or other
    taxes on account of payments to the Executive hereunder, but will remit the full amount of such payments to Executive and
    report them on IRS Form 1099. Reasonable expenses incurred by Executive in the course of performing the Services shall be
    reimbursed by the Company upon receipt and submission of evidence satisfactory to the Company, of the incurrence and purpose
    of each such expense and otherwise in accordance with the Company’s expense substantiation policy. Any line item expense
    of more than $1,500 will need prior Company approval.
	 	 	 
	 	iii.	It
    is understood and agreed that the Executive’s performance of the Services are as an independent contractor and not an
    employee of the Company, and the manner and means of the Executive’s provision of the Services will be under the Executive’s
    direction and control. Neither the Executive nor the Company shall make any commitments or create any obligations in the name
    of the other. Executive shall have no authority to bind the Company or assume any obligations or liabilities of any nature
    for or on behalf of the Company and the Executive will not have, and will not represent to third parties as having, actual
    or apparent power or authority to do or take any action for or on behalf of the Company as its agent or representative. Neither
    the Company nor any the Company entity shall provide to the Executive any employee benefits, including without limitation
    any medical, dental, pension, retirement, savings or insurance benefits which may be provided to employees of the Company
    or of any Company entity. Executive agrees to timely deposit all taxes required to be paid with respect to fees paid to it
    for the performance of the Services, and will indemnify the Company from all claims, interest or penalties relating to taxes
    due with respect to the fees provided by the Company to Executive. If requested, Executive agrees to promptly complete and
    deliver to the Company and execute IRS form 4669 (Statement of Payments Received) with respect to any amount payable hereunder.

 

    	 	 	 

    	 

    

 

	 	iv.	The
    term of the Services (the “Consulting Term”) shall commence on the Employment Termination Date and shall terminate
    six (6) months thereafter or upon such later date as may be mutually agreed upon by the Parties (the date on which the Consulting
    Term terminates, the “Consulting Termination Date”). Notwithstanding the foregoing, (x) the Company may terminate
    the Consulting Term prior to the end of the Consulting Term immediately upon written notice of termination for Cause (as defined
    below); provided that the Company shall pay the Executive’s fees through the date of delivery of such notice, (y) the
    Company or the Executive may terminate the Consulting Term prior to the end of the Consulting Term upon thirty (30) days prior
    written notice to the other party; provided that upon such notice by Executive, the Company in its sole discretion may immediately
    terminate the Consulting Term; provided further that the Company shall pay the Executive’s fee for the duration of such
    notice period, and (z) the Consulting Term shall terminate automatically and without any written notice upon the death or
    disability of Executive which renders Executive incapable of performing Executive’s duties hereunder. For purposes of
    this Agreement, “Cause” shall mean the Executive’s (i) negligence or willful misconduct in the performance
    of the Services; (ii) engagement in any felonious acts or other acts showing dishonesty or moral turpitude; or (iii) breach
    of any restrictive covenant set forth in any written agreement between Executive and the Company.

 

3.
Post-Consulting Severance Benefits. If Executive: (i) timely signs and return this Agreement to the Company; (ii)
complies fully with Executive’s obligations hereunder; and (iii) following the Consulting Termination Date, executes and
returns to the Company a Severance Agreement and General Release acceptable to the Company (the “Post-Consulting Release”),
which becomes effective within 60 days following the Consulting Termination Date, then the Company will provide Executive with
the following severance payments and benefits:

 

	 	i.	An
    amount equal to one hundred and thirty-one thousand eight hundred and seventy-five dollars ($131,875) (which amount, for the
    avoidance of doubt, is equal to 50% of Executive’s annual base salary in effect on the Employment Termination Date),
    payable in monthly installments over the six-month period following the Consulting Termination Date.

 

    	 	 	 

    	 

    

 

	 	ii.	If
    Executive properly and timely elects to continue health and dental coverage under the Company’s plan in accordance with
    the continuation requirements of COBRA, payment for the cost of the premiums for such coverages for Executive for a six (6)
    month period beginning on the Consulting Termination Date, or if earlier, through the date on which Executive becomes eligible
    for other group health coverage in connection with new employment.

 

Executive
understands and agrees that he is not entitled to any severance money or benefits, other than those offered in accordance with
the terms of this Agreement. Subject to Section 4 below and/or as otherwise provided by this Agreement, the severance payments
and benefits offered pursuant to this Section 3 will only be paid or provided if the Post-Consulting Release becomes effective
and within 60 days of the Consulting Termination Date. The severance payments and benefits will commence when the Post-Consulting
Release becomes effective. Notwithstanding the foregoing, if the 60 day period following the Consulting Termination Date ends
in a calendar year after the year in which the Consulting Termination Date occurs, the severance payments and benefits shall be
made no earlier than the first day of such later calendar year.

 

4.
Delay of Payment to Comply with Section 409A. Notwithstanding anything herein to the contrary, if on the Consulting
Termination Date Executive is a “specified employee” within the meaning of Section 409A (as defined below) and the
regulations promulgated thereunder, then if and to the extent required in order to avoid the imposition on Executive of any excise
tax under Section 409A, the Company shall delay the commencement of Executive’s severance payments (without any reduction)
by a period of six (6) months after the Consulting Termination Date. Any payments that would have been paid during such six (6)
month period but for the provisions of the preceding sentence shall be paid in a lump sum to Executive six (6) months and one
(1) day after the Consulting Termination Date. The 6-month payment delay requirement of this Section 4 shall apply only to the
extent that the payments under Section 3 are subject to Section 409A.

 

    	 	 	 

    	 

    

 

5.
409A Compliance. The following rules shall apply, to the extent necessary, with respect to distribution of the payments
and benefits, if any, to be provided to Executive under this Agreement. This Agreement is intended to comply with or be exempt
from Section 409A of the Code (“Section 409A”) and the Parties hereto agree to interpret, apply and administer this
Agreement in the least restrictive manner necessary to comply therewith and without resulting in any increase in the amounts owed
hereunder by the Company. Subject to the provisions in this Section 5, the severance payments and benefits pursuant to this Agreement
shall begin only upon the date of Executive’s “separation from service”. It is intended that each installment
of the severance payments and benefits provided under this Agreement, if any, shall be treated as a separate “payment”
for purposes of Section 409A. All reimbursements and in-kind benefits provided under this Agreement shall be made or provided
in accordance with the requirements of Section 409A, to the extent that such reimbursements or in-kind benefits are subject to
Section 409A, including, where applicable, the requirements that (i) the amount of expenses eligible for reimbursement during
a calendar year may not affect the expenses eligible for reimbursement in any other calendar year, (ii) the reimbursement of an
eligible expense will be made on or before the last day of the calendar year following the year in which the expense is incurred
and (iii) the right to reimbursement is not subject to set off or liquidation or exchange for any other benefit. Notwithstanding
anything herein to the contrary, the Company shall have no liability to Executive or to any other person if the payments and benefits
provided in this Agreement that are intended to be exempt from or compliant with Section 409A are not so exempt or compliant.

 

6.
Taxes. The Company may withhold from any amounts payable under this Agreement such federal, state or local income
taxes as may be appropriate.

 

7.
Executive’s General Release of Claims. In exchange for the payments and benefits described in this Agreement,
Executive knowingly and voluntarily releases the Company and its parent corporations, affiliates, subsidiaries, divisions, predecessors,
insurers, successors and assigns, and their current and former employees, attorneys, officers, directors, shareholders, agents,
representatives and employee benefit plans and programs and their administrators and fiduciaries (collectively referred to in
this Agreement and General Release as the “Released Parties”), from any and all claims, known and unknown, resulting
from anything which has happened up to the date Executive signs this Agreement, including any claim for attorneys’ fees,
relating to or arising out of Executive’s employment with the Company. For purposes of this release, “Executive”
includes Executive and his heirs and legal representatives.

 

Without
limiting the release in the prior paragraph in any way, Executive expressly waives and releases all claims relating to or arising
out of any conduct of the Released Parties with respect to Executive’s employment with the Company and/or any other aspect
of Executive’s employment with the Company and Executive’s termination of employment, including, but not limited to
all claims under:

 

	 	●	The
    Age Discrimination in Employment Act;
	 	 	 
	 	●	The
    National Labor Relations Act;
	 	 	 
	 	●	Title
    VII of the Civil Rights Act;
	 	 	 
	 	●	Sections
    1981 through 1988 of Title 42 of the United States Code;
	 	 	 
	 	●	The
    Employee Retirement Income Security Act (except for any vested benefits under any tax qualified benefit plan);

 

    	 	 	 

    	 

    

 

	 	●	The
    Genetic Information Nondiscrimination Act;
	 	 	 
	 	●	The
    Immigration Reform and Control Act;
	 	 	 
	 	●	The
    Americans with Disabilities Act;
	 	 	 
	 	●	The
    Occupational Safety and Health Act;
	 	 	 
	 	●	The
    Workers Adjustment and Retraining Notification Act;
	 	 	 
	 	●	The
    Fair Credit Reporting Act;
	 	 	 
	 	●	The
    Family and Medical Leave Act;
	 	 	 
	 	●	The
    Equal Pay Act;
	 	 	 
	 	●	The
    Uniformed Services Employment and Reemployment Rights Act;
	 	 	 
	 	●	Employee
    Polygraph Protection Act;
	 	 	 
	 	●	The
    Employee (whistleblower) civil protection provisions of the Corporate and Criminal Fraud Accountability Act (Sarbanes-Oxley
    Act);
	 	 	 
	 	●	The
    New Jersey Law Against Discrimination;
	 	 	 
	 	●	The
    New Jersey Civil Rights Act;
	 	 	 
	 	●	The
    New Jersey Family Leave Act;
	 	 	 
	 	●	The
    Millville Dallas Airmotive Plant Job Loss Notification Act;
	 	 	 
	 	●	The
    New Jersey Conscientious Employee Protection Act;
	 	 	 
	 	●	The
    New Jersey Equal Pay Law;
	 	 	 
	 	●	The
    New Jersey Occupational Safety and Health Law;
	 	 	 
	 	●	The
    New Jersey Smokers’ Rights Law;
	 	 	 
	 	●	The
    New Jersey Genetic Privacy Act;
	 	 	 
	 	●	The
    New Jersey Fair Credit Reporting Act;
	 	 	 
	 	●	The
    New Jersey Statutory Provision Regarding Retaliation/Discrimination for Filing A Workers’ Compensation Claim;
	 	 	 
	 	●	The
    Florida Civil Rights Act;
	 	 	 
	 	●	The
    Florida Whistleblower Protection Act;
	 	 	 
	 	●	The
    Florida Workers’ Compensation Retaliation provision;
	 	 	 
	 	●	The
    Florida Minimum Wage Act;
	 	 	 
	 	●	The
    Florida Fair Housing Act;
	 	 	 
	 	●	other
    federal, state or local law equal employment opportunity or other laws, regulations, or ordinances;
	 	 	 
	 	●	breach
    of contract; quasi contract; negligence; interference with contract/business advantage; fraud; defamation; intentional infliction
    of emotional distress;
	 	 	 
	 	●	common
    law wrongful discharge from employment; and
	 	 	 
	 	●	any
    other duty or obligation of any kind or description to the fullest extent permissible by law.

 

    	 	 	 

    	 

    

 

Executive
does not waive or release: (1) his right to enforce or challenge this Agreement and General Release; (2) any vested rights which
Executive may have under any employer sponsored benefit plan; (3) the right to file any unwaivable charge or complaint with a
government administrative agency (although Executive does waive and release any right to recover damages in connection with any
such charge or complaint relating to anything which has happened up to the date Executive signs this Agreement); (4) rights or
claims which cannot lawfully be released; (5) any right to defense or indemnification based upon Executive’s past conduct
within the course and scope of Executive’s duties for the Company that Executive may have whether based on Company bylaws,
state law, or insurance policy; and (6) rights or claims arising after the date Executive signs this Agreement.

 

Executive
represents that as of the date he signs this Agreement and General Release, he is unaware of any work related illness or injury.
Executive also acknowledges and agrees that he has fully and timely received all wages, overtime compensation, bonuses, commissions,
benefits, and/or other amounts due in connection with his employment with and termination from the Company.

 

Executive
represents that, as of the date he signs this Agreement, he has not filed any charge, complaint, claim, or action with any court,
organization, governmental entity, or administrative agency against the Company, or any of the other Released Parties.

 

8.
The Company’s General Release of Claims. In exchange for the mutual promises contained herein, the Company,
and its parent corporations and subsidiaries knowingly and voluntarily releases Executive and his heirs and legal representatives
from any and all claims, known and unknown, resulting from anything which has happened up to the date Company signs this Agreement
arising out of Executive’s service to the Company or the termination thereof, including any claim for attorneys’ fees.
The foregoing will not be deemed to release Executive from claims (a) to enforce this Agreement and General Release, (b) claims
arising from acts or omissions by Executive that would constitute a crime, or (c) claims that are not known to any member of the
Company’s Board of Directors (provided that a claim will be deemed known if the basis for each material element of the claim
could have been ascertained by the Company’s Board of Directors prior to the date hereof upon reasonable inquiry).

 

9.
Restrictive Covenants and Return of Property. Executive represents that Executive has not divulged any proprietary
or confidential information of the Company and will remain subject to the confidentiality and other covenants contained in the
Confidential Information, Non-Disclosure, Non-Competition, Non-Solicitation, and Rights to Intellectual Property Agreement previously
entered into by Executive in favor of the Company (the “Confidential Information, Non-Disclosure, Non-Competition, Non-Solicitation,
and Rights to Intellectual Property Agreement”), which is incorporated by reference herein. Executive represents that Executive
has returned all of the Company’s property, documents, and/or any confidential or proprietary information in Executive’s
possession or control. Executive also agrees that Executive is in possession of all of Executive’s property that Executive
had at the Company’s premises and that the Company is not in possession of any of Executive’s property.

 

    	 	 	 

    	 

    

 

10.
Governing Law and Interpretation. This Agreement shall be interpreted in accordance with the laws of the State of
New Jersey without regard to principles of conflicts of laws.

 

11.
Severability. Should any provision or part of any provision of this Agreement be declared illegal, unenforceable,
or ineffective in any legal forum, that provision or part of that provision shall immediately become null and void, but the rest
of this Agreement and General Release will remain in full force and effect.

 

12.
No Admission of Wrongdoing and Attorneys’ Fees. Neither Party, by signing this Agreement, admits to any wrongdoing
or liability to the other. Both Executive and the Company deny any wrongdoing or liability. The Parties shall each bear their
own attorneys’ fees and/or expenses incurred in connection with this Agreement and no Party shall be deemed a prevailing
Party for any purpose.

 

13.
Amendment. This Agreement may not be modified, altered or changed except in writing and signed by both Executive
and the Company.

 

14.
Entire Agreement. This Agreement and General Release sets forth the entire agreement between Executive and the Company
with respect to the subject matter hereof. This Agreement and General Release supersedes and replaces any and all prior agreements
or understandings between Executive and the Company, except the Confidentiality, Non-Competition, and Non-Solicitation Agreement
which shall survive and continue to remain in full force and effect. Executive acknowledges that Executive has not relied on any
representations, promises, or agreements of any kind made to Executive in connection with Executive’s decision to accept
this Agreement and General Release, except for those set forth in this Agreement and General Release.

 

15.
Representation by Counsel. Executive acknowledges that he has had ample time and opportunity to consult with the
attorney of his choice in connection with his execution of this Agreement if he elected to do so; that he has carefully read and
fully understands all of the provisions of this Agreement; and that he has had adequate time to review this Agreement and the
General Release contained in this Agreement.

 

16.
Agreement is Joint Product. The Parties acknowledge that this Agreement is a joint product and shall not be construed
for or against any Party on the ground of sole authorship. This Agreement may be executed in multiple originals, each of which
shall be considered an original instrument, but all of which shall constitute one agreement, and shall bind the Parties hereto
and their successors, heirs, assigns, and legal representatives.

 

    	 	 	 

    	 

    

 

17.
Counterparts. This Agreement may be executed in counterparts, each being deemed an original document. This Agreement
shall be binding upon the execution and delivery by facsimile or email by all Parties to this Agreement as if the same were manually
executed and delivered by such Parties. The Parties agree to promptly deliver to each other original executed counterparts of
this Agreement.

 

18.
Assignment. Neither Party may assign such Party’s rights or obligations hereunder without the prior written
consent of the other Party.

 

19.
No Waiver. No waiver by any Party hereto of any breach of this Agreement by any other Party shall operate or be
construed as a waiver of any other or subsequent breach.

 

20.
Non-Disparagement. Executive agrees that he will not make any defamatory remarks about the Company or its officers,
directors, employees, or predecessor or successor corporations. Similarly, the Company (meaning, solely for this purpose, the
executive officers and directors of the Company and other persons authorized to make official communications on behalf of the
Company) will not make any defamatory remarks about Executive. Notwithstanding the foregoing, in no event will any legally required
disclosure or action be deemed to violate this paragraph, regardless of the content of such disclosure or the nature of such action.

 

[signature
page follows]

 

    	 	 	 

    	 

    

 

	EXECUTIVE	 
	 	 
	/s/
    James E Early	 
	James
    E. Early	 
	 	 
	Managing
    Member, Early Financial Consulting, LLC	 
	 	 
	Interpace
    Biosciences, Inc.	 
	 	 
	/s/
    Jack E. Stover	 
	Jack
    E. Stover	 
	Chief
    Executive OfficerExhibit
10.3

 

First
AMENDMENT TO

Amended and Restated EMPLOYMENT AGREEMENT

 

THIS
FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT is dated January 29th, 2020 by and between Interpace
Biosciences, Inc. (“Company”) and Jack E. Stover (the “Executive”).

 

WHEREAS,
the Company and the Executive are parties to that certain Amended and Restated Employment Agreement dated as of December 5, 2018
(the “Employment Agreement”); and

 

WHEREAS,
the Company and the Executive desire to amend the Employment Agreement as set forth herein.

 

NOW,
THEREFORE, in consideration of these premises and intending to be legally bound hereby, the Employment Agreement is hereby
amended as follows, effective on the date first above written:

 

1.
The following shall replace Section 1.9 of the Employment Agreement:

 

“1.9
“Transaction” means any of the following events following the date hereof: (i) any merger by the Company into
another corporation or corporations which results in the stockholders of the Company immediately prior to such transaction owning
less than 51% of the surviving corporation; (ii) any acquisition (by purchase, lease or otherwise) of all or substantially all
of the assets of the Company by any “person” (as such term is used in Sections 13(d) or 14(d) of the Securities Exchange
Act of 1934, as amended (the “Exchange Act”)), corporation or other entity or group thereof acting jointly;
(iii) the acquisition of beneficial ownership of voting securities of the Company (defined as common stock of the Company or any
securities having voting rights that the Company may issue in the future) or rights to acquire voting securities of the Company
(defined as including, without limitation, securities that are convertible into voting securities of the Company (as defined above)
and rights, options, warrants and other agreements or arrangements to acquire such voting securities) by any other “person”
(as such term is used in Sections 13(d) or 14(d) of the Exchange Act), corporation or other entity or group thereof acting jointly,
in such amount or amounts as would permit such person, corporation or other entity or group thereof acting jointly to elect a
majority of the members of the Board, as then constituted; or (iv) the acquisition of beneficial ownership, directly or indirectly,
of voting securities and rights to acquire voting securities having voting power equal to 51% or more of the combined voting power
of the Company’s then outstanding voting securities by any “person” (as such term is used in Sections 13(d)
or 14(d) of the Exchange Act), corporation or other entity or group thereof acting jointly. Additionally, any transaction that
involves a mere change in identity, form or place of organization with the meaning of Section 368(a)(1)(F) of the Code, or a transaction
of similar effect or which is used to obtain a line of credit or other financing, shall not constitute a Transaction.

 

2.
The following sentence shall be inserted following the last sentence of Section 3.4 of the Employment Agreement:

 

“In
the event of a Transaction on or following January 29, 2020, each of the Executive’s then-outstanding equity awards shall
be eligible to vest and become exercisable in full immediately prior to the occurrence of such Transaction (including any such
awards that vest in whole or in part based on the attainment of performance-vesting conditions that shall be deemed achieved at
the target level of the applicable award agreement), subject to the Executive’s continuous employment through such Transaction.”

 

3.
The Employment Agreement, as amended by the foregoing changes, is hereby ratified and confirmed in all respects.

 

[Remainder
of page intentionally omitted]

 

    	 	 	 

    	 

    

 

IN
WITNESS WHEREOF, the parties have executed this First Amendment to the Employment Agreement as of the date first above written.

 

	 	INTERPACE BIOSCIENCES, INC.
	 	 	 
	 	By:	/s/
    Stephen Sullivan
	 	Name:	Stephen
    Sullivan
	 	Title:	Chairman
    of the Board
	 	 	 
	 	EXECUTIVE
	 	 	 
	 	By:	/s/
    Jack E. Stover
	 	Name:	Jack
    E. Stover

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}]]